บทความที่มีข้อกำหนดการเข้าถึงสาธารณะ - Craig Horbinskiดูข้อมูลเพิ่มเติม
ไม่มีให้ใช้งานในทุกที่: 2
Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours
C Horbinski, T Berger, RJ Packer, PY Wen
Nature Reviews Neurology 18 (9), 515-529, 2022
ข้อกำหนด: US National Institutes of Health
Discovery of novel serum biomarkers of gliomas by proximity extension assay
A Ghorbani, LM Avery, D Sohaei, M Richer, C Horbinski, K McCortney, ...
ข้อกำหนด: Canadian Cancer Society
มีให้ใช้งานในบางที่: 202
Epidemiologic and molecular prognostic review of glioblastoma
JP Thakkar, TA Dolecek, C Horbinski, QT Ostrom, DD Lightner, ...
Cancer epidemiology, biomarkers & prevention 23 (10), 1985-1996, 2014
ข้อกำหนด: US National Institutes of Health
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
PY Wen, M Weller, EQ Lee, BM Alexander, JS Barnholtz-Sloan, ...
Neuro-oncology 22 (8), 1073-1113, 2020
ข้อกำหนด: US National Institutes of Health
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
J Zhao, AX Chen, RD Gartrell, AM Silverman, L Aparicio, T Chu, ...
Nature medicine 25 (3), 462-469, 2019
ข้อกำหนด: US National Science Foundation, US National Institutes of Health, V …
CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells
AL Chang, J Miska, DA Wainwright, M Dey, CV Rivetta, D Yu, D Kanojia, ...
Cancer research 76 (19), 5671-5682, 2016
ข้อกำหนด: US National Institutes of Health
An overview of meningiomas
RA Buerki, CM Horbinski, T Kruser, PM Horowitz, CD James, RV Lukas
Future oncology 14 (21), 2161-2177, 2018
ข้อกำหนด: US National Institutes of Health
Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer
ML Zhu, CM Horbinski, M Garzotto, DZ Qian, TM Beer, N Kyprianou
Cancer research 70 (20), 7992-8002, 2010
ข้อกำหนด: US National Institutes of Health
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
A Piunti, R Hashizume, MA Morgan, ET Bartom, CM Horbinski, ...
Nature medicine 23 (4), 493-500, 2017
ข้อกำหนด: US National Institutes of Health, European Commission
Mitochondrial control by DRP1 in brain tumor initiating cells
Q Xie, Q Wu, CM Horbinski, WA Flavahan, K Yang, W Zhou, ...
Nature neuroscience 18 (4), 501-510, 2015
ข้อกำหนด: US National Institutes of Health
Preferential iron trafficking characterizes glioblastoma stem-like cells
DL Schonberg, TE Miller, Q Wu, WA Flavahan, NK Das, JS Hale, ...
Cancer cell 28 (4), 441-455, 2015
ข้อกำหนด: US National Institutes of Health, Canadian Institutes of Health Research
Glioma progression is shaped by genetic evolution and microenvironment interactions
FS Varn, KC Johnson, J Martinek, JT Huse, MLP Nasrallah, P Wesseling, ...
Cell 185 (12), 2184-2199. e16, 2022
ข้อกำหนด: Fundação de Amparo à Pesquisa do Estado de São Paulo, US Department of …
Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1–mediated lipogenesis
F Geng, X Cheng, X Wu, JY Yoo, C Cheng, JY Guo, X Mo, P Ru, B Hurwitz, ...
Clinical Cancer Research 22 (21), 5337-5348, 2016
ข้อกำหนด: US National Institutes of Health
Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression
JS Hale, B Otvos, M Sinyuk, AG Alvarado, M Hitomi, K Stoltz, Q Wu, ...
Stem cells 32 (7), 1746-1758, 2014
ข้อกำหนด: US National Institutes of Health
Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes
F Nassiri, A Chakravarthy, S Feng, SY Shen, R Nejad, JA Zuccato, ...
Nature medicine 26 (7), 1044-1047, 2020
ข้อกำหนด: US National Institutes of Health, Canadian Institutes of Health Research …
Mutant IDH1 and seizures in patients with glioma
H Chen, J Judkins, C Thomas, M Wu, L Khoury, CG Benjamin, D Pacione, ...
Neurology 88 (19), 1805-1813, 2017
ข้อกำหนด: US National Institutes of Health
A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma
P Kumthekar, CH Ko, T Paunesku, K Dixit, AM Sonabend, O Bloch, M Tate, ...
Science translational medicine 13 (584), eabb3945, 2021
ข้อกำหนด: US Department of Energy, US National Institutes of Health
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
F Nassiri, Y Mamatjan, S Suppiah, JH Badhiwala, S Mansouri, S Karimi, ...
Neuro-oncology 21 (7), 901-910, 2019
ข้อกำหนด: US National Institutes of Health, Canadian Institutes of Health Research
Targeting DGAT1 ameliorates glioblastoma by increasing fat catabolism and oxidative stress
X Cheng, F Geng, M Pan, X Wu, Y Zhong, C Wang, Z Tian, C Cheng, ...
Cell metabolism 32 (2), 229-242. e8, 2020
ข้อกำหนด: US National Institutes of Health
Cancer-associated IDH1 promotes growth and resistance to targeted therapies in the absence of mutation
AE Calvert, A Chalastanis, Y Wu, LA Hurley, FM Kouri, Y Bi, M Kachman, ...
Cell reports 19 (9), 1858-1873, 2017
ข้อกำหนด: US Department of Defense, US National Institutes of Health
แหล่งที่มาและข้อมูลกองทุนดำเนินการโดยโปรแกรมคอมพิวเตอร์โดยอัตโนมัติ